Aromasin & Neoplasm progression

6.5%

of users reported Neoplasm progression

46.9%

also reported Death

100.0%

are women

Death

46.9%

Severe reaction

37.5%

Hospitalization

15.6%

Aromasin: general information

30 - 39 years

0.9%

40 - 49 years

4.5%

50 - 59 years

16.2%

60 - 69 years

34.2%

70 - 79 years

30.8%

80 - 89 years

11.5%

90 - 99 years

1.8%